Cytox Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Cytox Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10311
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cytox Ltd (Cytox) is a prognostic and diagnostic service provider that develops neurodegenerative disorders services. The company offers development of tests to identify individuals at risk of cognitive decline, Alzheimer’s disease and other dementias and its blood tests are used to predict that patients with MCI will develop Alzheimer’s disease. Its biomarkers are based on the cell cycle hypothesis of Alzheimer’s disease discovered. Cytox offers Cytox variatech SNP research assay that is a biomarker research assay to reduce screening failure in clinical trials and helps in novel drug discovery. The company also provides biomarker services to pharmaceutical industry clients to conduct clinical trials with drugs for the treatment of Alzheimer’s disease and mild cognitive impairment. It partners with pharmaceutical industry and academic researchers to develop blood-based assays. Cytox is headquartered in Oxford, the UK.

Cytox Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cytox Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cytox Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cytox Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cytox Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Cytox Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cytox Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Cytox Raises USD3.3 Million in Venture Financing 10
Cytox Raises US$2.5 Million In Venture Financing 12
Cytox Raises USD5.5 Million in Financing Round 13
Partnerships 14
Cytox Enters into Joint Development Partnership with Affymetrix 14
Alta Innovations Enters Into Licensing Agreement With Cytox 15
Cytox Ltd – Key Competitors 16
Cytox Ltd – Key Employees 17
Cytox Ltd – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Strategy And Business Planning 19
May 08, 2018: Cytox in collaboration with AKESOgen extends genetic test for assessing Alzheimer s disease risk to include saliva samples 19
Other Significant Developments 20
May 22, 2018: Cytox launches collaboration agreement with Mayo Clinic to evaluate novel genetic based approaches for assessing Alzheimer’s risk 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Cytox Ltd, Medical Equipment, Key Facts 2
Cytox Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Cytox Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cytox Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cytox Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cytox Ltd, Deals By Market, 2012 to YTD 2018 8
Cytox Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cytox Raises USD3.3 Million in Venture Financing 10
Cytox Raises US$2.5 Million In Venture Financing 12
Cytox Raises USD5.5 Million in Financing Round 13
Cytox Enters into Joint Development Partnership with Affymetrix 14
Alta Innovations Enters Into Licensing Agreement With Cytox 15
Cytox Ltd, Key Competitors 16
Cytox Ltd, Key Employees 17

List of Figures
Cytox Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Cytox Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Cytox Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Cytox Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Cytox Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cytox Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Cytox Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cytox Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Cytox Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • DHL Parcel UK Ltd:企業の戦略的SWOT分析
    DHL Parcel UK Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • China National Nuclear Power Co Ltd (601985):電力:M&Aディール及び事業提携情報
    Summary China National Nuclear Power Co Ltd (CNNPC), a subsidiary of China National Nuclear Corp is a nuclear energy company. The company provides activities such as development, investment, construction, operations and management of nuclear power projects and technical research in the safe operatio …
  • Freeborn-Mower Cooperative Services:企業の戦略的SWOT分析
    Freeborn-Mower Cooperative Services - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • American Outdoor Brands Corp:企業の戦略・SWOT・財務情報
    American Outdoor Brands Corp - Strategy, SWOT and Corporate Finance Report Summary American Outdoor Brands Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • PPL Corp:企業の発電所・SWOT分析2018
    PPL Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executive …
  • Black Hills Corporation (BKH):石油・ガス:M&Aディール及び事業提携情報
    Summary Black Hills Corp (BHC) is a vertically-integrated energy company which offers electricity and natural gas. The company produces, transmits, and distributes electricity; and sells natural gas on retail and wholesale basis. It generates electricity from natural gas, coal, diesel oil, and wind …
  • Lenovo Group Ltd (992):企業の財務・戦略的SWOT分析
    Lenovo Group Ltd (992) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Bank of Jordan (BOJX):企業の財務・戦略的SWOT分析
    Summary Bank of Jordan is a banking service provider. The company offers corporate services, leasing services, retail services, SMEs services and securities services. It also provides car loans, mortgage, personal loans and credit cards. Bank of Jordan’s retail services include accounts and deposits …
  • Societe Nationale Industrielle et Miniere:企業の戦略・SWOT・財務情報
    Societe Nationale Industrielle et Miniere - Strategy, SWOT and Corporate Finance Report Summary Societe Nationale Industrielle et Miniere - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • United-Guardian Inc (UG):企業の財務・戦略的SWOT分析
    Summary United-Guardian Inc (United-Guardian) is a diversified company that manufactures and markets healthcare products. The company offers pharmaceuticals, cosmetic ingredients, health care products and proprietary industrial products, among others. It provides medical devices such as lubrajel flu …
  • Caverion Corp:企業の戦略・SWOT・財務情報
    Caverion Corp - Strategy, SWOT and Corporate Finance Report Summary Caverion Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Titan Pharmaceuticals Inc (TTNP):企業の財務・戦略的SWOT分析
    Summary Titan Pharmaceuticals Inc (Titan) is a pharmaceutical company that develops therapeutics for the treatment of serious medical disorders. The company develops drugs using ProNeura, a proprietary drug delivery platform, for the treatment of chronic diseases. It product portfolio provides probu …
  • The Mauritius Commercial Bank Limited:企業の戦略・SWOT・財務情報
    The Mauritius Commercial Bank Limited - Strategy, SWOT and Corporate Finance Report Summary The Mauritius Commercial Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Cyprotex Ltd-医療機器分野:企業M&A・提携分析
    Summary Cyprotex Ltd (Cyprotex), a subsidiary of Evotec AG is a provider of ADME-Tox contract research services. It provides these services to the biotechnology, pharmaceutical, cosmetics/personal care and chemical industries. The company’s core capabilities include high quality mechanistic toxicolo …
  • Nampak Limited:企業の戦略・SWOT・財務分析
    Nampak Limited - Strategy, SWOT and Corporate Finance Report Summary Nampak Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • CymaBay Therapeutics Inc (CBAY):製薬・医療:M&Aディール及び事業提携情報
    Summary CymaBay Therapeutics Inc (CymaBay), formerly Metabolex Inc is a clinical-stage biopharmaceutical company that develops therapeutics to treat diabetes, orphan diseases and related metabolic disorders. The company’s pipeline products comprise Arhalofenate, an oral small molecule intended for t …
  • Slater and Gordon Limited:企業の戦略・SWOT・財務情報
    Slater and Gordon Limited - Strategy, SWOT and Corporate Finance Report Summary Slater and Gordon Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Och-Ziff Capital Management Group LLC (OZM):企業の財務・戦略的SWOT分析
    Summary Och-Ziff Capital Management Group LLC (Oz Management) is an alternative asset management firm that provides asset management services. The firm’s services portfolio includes portfolio management, private investments, funds management, and equity funds investment and management services. Its …
  • Cognizant Technology Solutions Corporation:戦略・SWOT・企業財務分析
    Cognizant Technology Solutions Corporation - Strategy, SWOT and Corporate Finance Report Summary Cognizant Technology Solutions Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • China Development Bank
    China Development Bank - Strategy, SWOT and Corporate Finance Report Summary China Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆